Tagged with Intellectual Property

Abdulaziz Alswailem – CEO, Saudi Authority for Intellectual Property (SAIP)
Enabling Innovation in the UAE: Incentives, Regulatory Policies & IP Rights Protection
Milind Antani – Lead, Pharma, Life Science and Healthcare Practice; Head, Social Sector Practice, Nishith Desai Associates
How Patent Analytics Can Show Pharma’s Top Performers
Charles Gore – Executive Director, Medicines Patent Pool (MPP)
Pharma Industry Leaders Lambast IP Waivers & Weigh In on Vaccine Inequity
IP in Saudi Arabia: Room for Improvement?
The WHO Pandemic Treaty & Three Key Lessons from the COVID-19 Response
Mexico: Despite Hurdles, Pharma Market Remains Attractive
Interview: Sergio Olivares – Managing Director, Olivares, Mexico
Interview: Leonardo Vingiani – Director, ASSOBIOTEC, Italy
Interview: Agustín Rullán – Dean, College of Engineering, UPR Mayagüez, Puerto Rico
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here